Poland· PL-100383972
Suliqua
A insulin glargine and lixisenatide product containing insulinum glarginum + lixisenatidum, registered in Poland by Sanofi Winthrop Industrie. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Insulin glargine and lixisenatide is registered in 10 of 19 countries.
Countries holding a registration under ATC A10AE54 (insulin glargine and lixisenatide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Insulin glargine and lixisenatide · ATC A10AE54
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Insulinum glarginum + Lixisenatidum
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Poland (PL)
- ATC code
- A10AE54
- ATC class
- Insulin glargine and lixisenatide
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
1 priced- gtin05909991415211
- gtin059099913159243 wstrzykiwacze po 3 mlPLN 405.88
- gtin05909991315931
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin glargine and lixisenatide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSULIQUASanofi Winthrop Industrie, Gentilly
- SwedenSuliqua 100 enheter/ml+33 mikrogram/ml Injektionsvätska, lösning i förfylld injektionspennaSanofi Winthrop Industrie
- SpainSULIQUA 100 UNIDADES/ML + 33 MICROGRAMOS/ML SOLUCION INYECTABLE EN PLUMA PRECARGADASanofi Winthrop Industrie
- FinlandSuliquaSanofi Winthrop Industrie
- United KingdomSuliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pensSanofi
- IrelandSuliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled penSanofi-Aventis Groupe
- SwitzerlandSuliqua 100/33, solution injectableSanofi-Aventis (Suisse) SA
- IcelandSuliquaSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Suliqua
- Liechtenstein · Suliqua
- Norway · Suliqua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7a77e8b-2307-441d-a29c-f06de89687e1 GET /v1/drugs/f7a77e8b-2307-441d-a29c-f06de89687e1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "100 j./ml + 50 mcg/ml",
"packaging": "05909991315924 ¦ Rp ¦ EU/1/16/1157/001 ¦ 120058\n3 wstrzykiwacze 3 ml\n05909991315931 ¦ Rp ¦ EU/1/16/1157/002 ¦ 120059\n5 wstrzykiwaczy 3 ml\n05909991415211 ¦ Rp ¦ EU/1/16/1157/005 ¦ 134213\n10 wstrzykiwaczy 3 ml",
"substance": "Insulinum glarginum 100 j.m./1 ml + Lixisenatidum 50 mcg/1 ml",
"common_name": "Insulinum glarginum + Lixisenatidum",
"pl_product_id": "100383972",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about insulin glargine and lixisenatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.